Leukemia

Early Testing Completed On Experimental Drug

Published in Blood Weekly, June 28th, 2001

Results of a small Phase I study suggest a new leukemia drug, R115777, could be an effective treatment.

The research was conducted at the University of Rochester Medical Center and written up for the June 1, 2001, issue of the journal Blood.

Tested on 34 patients, R115777 was less toxic than traditional chemotherapy. In addition, 30% of the patients who took R115777 went into partial or complete remission.

This result was somewhat unexpected, physicians say; early studies of experimental drugs are designed to assess safety, toxicity, and whether the treatment works the way it was meant to work. It's unusual for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-06-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry